MetLife’s Recent Financial Moves and Market Performance

MetLife's Recent Financial Moves and Market Performance

Tue, July 07, 2026

MetLife’s Recent Financial Moves and Market Performance

Dividend Increase Reflects Financial Strength

In April 2026, MetLife, Inc. (NYSE: MET) announced a 4.4% increase in its common stock dividend, raising it to $0.5925 per share. This marks a consistent upward trend, with the company achieving an 8.1% compound annual growth rate in dividends since 2011. The dividend was payable on June 9, 2026, to shareholders of record as of May 12, 2026. President and CEO Michel Khalaf stated that this increase reflects MetLife’s durable earnings power and disciplined capital management.

Strong First Quarter 2026 Financial Results

MetLife reported robust financial results for the first quarter of 2026. Net income rose by 30% to $1.1 billion, or $1.74 per share. Adjusted earnings saw an 18% increase, reaching $1.6 billion, driven by higher variable investment income, volume growth, and favorable underwriting. Premiums, fees, and other revenues increased by 5% to $14.3 billion. The company also returned over $1.1 billion to shareholders through share repurchases and common stock dividends. Holding company cash and liquid assets totaled $3.9 billion at the quarter’s end, positioning MetLife at the top of its target range.

Market Performance and Analyst Outlook

As of July 6, 2026, MetLife’s stock price stood at $90.46, reflecting a slight decrease of 0.46% from the previous close. The stock’s intraday high reached $91.26, with a low of $89.00. The company’s market capitalization is approximately $58.2 billion, with a price-to-earnings (P/E) ratio of 17.5 and earnings per share (EPS) of $5.17. Analyst consensus rates MET stock as a “Buy,” with a 12-month price target of $92.25, suggesting a potential upside of 2.43% from the current price.

Conclusion

MetLife’s recent financial decisions, including the dividend increase and strong first-quarter results, underscore the company’s solid financial health and commitment to shareholder value. These developments have contributed to the stock’s stable performance and positive analyst outlook. Investors should monitor MetLife’s ongoing financial strategies and market conditions to make informed decisions.